<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>28283215</identifier>
<setSpec>1699-7980</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Masarwa, I</dc:author>
<dc:author>Shprits, S</dc:author>
<dc:author>Nativ, O</dc:author>
<dc:author>Bahouth, Z</dc:author>
<dc:author>Halachmi, S</dc:author>
<dc:author>Moskovitz, B</dc:author>
<dc:author>Avitan, O</dc:author>
<dc:author>Burbara, Y</dc:author>
<dc:description xml:lang="en">OBJECTIVES To report the results of the use of Bovine Serum Albumin-Glutaraldehyde tissue adhesive (BioGlue®) for tumor bed closure in open nephron-sparing surgery (NSS). MATERIALS AND METHODS The cohort included 255 patients with enhancing renal mass who underwent open NSS. We used open flank approach, with in-situ hypothermia and enucleation of the tumor. For tumor bed closure, we used the BioGlue® sealant for tumor bed filling, without suturing the edges. RESULTS Mean patients' age was 65.4 years. 5.1% of patients had pre-operative chronic renal failure. Mean renal mass diameter was 4.2±1.6cm and mean R.E.N.A.L nephrometry score was 8.0±1.6. Mean ischemia time was 21.8±7.6. Mean estimated blood loss was 42±82ml and only two patients required blood transfusion. Urine leak and pseudo-aneurysm were recorded in two and one patient, respectively. None of the operations were converted to radical nephrectomy. The average change between post-operative and pre-operative eGFR (Δ=-1.7ml/min) was insignificant in a mean follow-up of 30.1±29.6 months. The 10-year recurrence-free survival rate was 99% and the 10-year overall survival rate was 85%. CONCLUSIONS The use of BioGlue® alone for hemostasis after NSS is a feasible and safe alternative to classical suturing. Its use enables satisfactory functional outcome and could potentially reduce ischemia time.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>Enucleation</dc:subject>
<dc:subject>Nephron-sparing surgery</dc:subject>
<dc:subject>Cirugía preservadora de nefronas</dc:subject>
<dc:subject>enucleación</dc:subject>
<dc:subject>BioGlue</dc:subject>
<dc:subject>Tissue sealant</dc:subject>
<dc:subject>Sellador de tejidos</dc:subject>
<dc:subject>Glomerular filtration rate</dc:subject>
<dc:subject>Tasa de filtración glomerular</dc:subject>
<dc:date>2017 Oct </dc:date>
<dc:title xml:lang="es">El uso de adhesivo tisular de albúmina-glutaraldehído sérico bovino (BioGlue®) para el cierre del lecho tumoral después de una nefrectomía parcial abierta.</dc:title>
<dc:title xml:lang="en">The use of bovine serum albumin-glutaraldehyde tissue adhesive (BioGlue®) for tumor bed closure following open partial nephrectomy.</dc:title>
<dc:publisher>Actas urologicas espanolas</dc:publisher>
</metadata>
</record>
</pubmed-document>
